Trinity researchers map pancreatic cancer's complex vulnerabilities in landmark review

Pancreatic cancer remains one of the deadliest cancers with only 13% of patients surviving five years after diagnosis, representing significant mortality burden.

For decades, pancreatic cancer has claimed lives at a rate that humbles medicine — only one in eight patients survives five years. Researchers at Trinity College Dublin have now done what individual experiments rarely permit: they have stepped back and mapped the whole terrain, revealing a disease that does not fail through a single flaw but through the coordinated interplay of genetics, immunity, metabolism, and even the body's own microbial inhabitants. Their review, published in Cancer Letters, does not promise a cure — it offers something more foundational: a clearer understanding of why t

Trinity researchers map pancreatic cancer's complex vulnerabilities in landmark review

Cobertura Relacionada

Receba o Register no seu e-mail